Exploring potential anti-inflammatory effects of THC/CBD 1:20 medicinal cannabis product in patients with advanced cancer - Cann-inflamm (TRI-LINC project led by Mater Research) (2023–2026)
- Grant type:
- Mater Research Ltd
- Researchers:
-
-
- Funded by:
- Mater Research Limited
